Product
Supplier
Encyclopedia
Inquiry
Abaloparatide buy - large image1
Abaloparatide buy - image1

Abaloparatide

71 Inquiries

Unit Price: Get Latest Price
CAS No.:

247062-33-5

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Hangzhou

Brand:

fullas

Packaging:

1g

Price valid (until):

2026-03-04

Company Type:
Distributor
Location:
China
Qualification:
Main Products:

GLP-1,Tirzepatide,Retatrutide,MOTS-c

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Abaloparatide, sold under the brand name Tymlos, is a parathyroid hormone-related protein (PTHrP) analog indicated for the treatment of osteoporosis. Similar to teriparatide—another agent in this class—and distinct from bisphosphonates, it acts as an anabolic (bone-forming) drug. The medication received US approval in 2017 for the management of postmenopausal osteoporosis.

    Filling Status: USDM

    Items Specifications






    ECHEMI Editorial Reference
    Abaloparatide is a parathyroid hormone receptor 1 (PTHR1) analog and a selective PTHR1 activator. Abaloparatide enhances Gs/cAMP signaling and β-arrestin recruitment. Abaloparatide enhances bone formation and cortical structure in mice. Abaloparatide is used to treat osteoporosis.

    Basic Info
    Product Name:

    Abaloparatide

    Other Name:

    Abaloparatide;Abaloparatide (BA058)

    CAS No.:

    247062-33-5

    Molecular Formula:

    C174H300N56O49

    InChIKeys:

    BVISQZFBLRSESR-XSCWXTNMSA-N

    Molecular Weight:

    3960.5896

    EC Number:

    218-362-5

    Color/Form:

    White to off-white

  • Seller Information
    Business Type:

    Distributor

    Main Products:

    GLP-1,Tirzepatide,Retatrutide,MOTS-c

    Location:

    5 Euro America Financial City EFC Yuhang District Hangzhou China 311100 P.R.China

    Payment Terms:

    TT against copy of documents,L/C,TT against B/L draft before shipment

    Average lead Time:

    1

    Year of Establishment:

    2023

  • Inquiry History
    71 Inquiries
    Country Product Purchase Quantity Date Posted
    Australia

    High Quality Abaloparatide 99% white powder 247062-33-5 -Shaanxi Dideu Medichem Co.Ltd

    1 G Aug 15, 2026
    United States

    Abaloparatide – Sequence length: 34 amino acids

    10 MG Aug 15, 2025
    United Kingdom

    Abaloparatide

    10 G Dec 18, 2025
    Italy

    abaloparatide

    1 G Aug 20, 2026
    China

    Abaloparatide

    10 MT Aug 15, 2026
    United Kingdom

    Abaloparatide

    1 MG Jul 24, 2026
    Kazakstan

    Abaloparatide

    10 MG Jul 21, 2026
    Uzbekistan

    Abaloparatide acetate

    1 G Jul 20, 2026
    Netherlands

    Abaloparatide

    50 MG Jul 20, 2026
    Netherlands

    Abaloparatide

    15 MG Jul 11, 2026
    United States

    Abaloparatide

    1 G Jul 10, 2026
    Australia

    Abaloparatide

    25 MG Jun 28, 2026
    United States

    abaloparatide-cas247062

    100 MG Jun 3, 2026
    United States

    Abaloparatide

    Jun 3, 2026
    United States

    abaloparatide

    1 G May 23, 2026
    United States

    Abaloparatide

    100 MG May 20, 2026
    United States

    Abaloparatide

    1 G Mar 24, 2026
    United States

    Abaloparatide

    30 G Mar 19, 2026
    United Kingdom

    Abaloparatide

    1 G Mar 18, 2026
    United States

    usa warehouse Abaloparatide 99% white powder

    10 MG Feb 5, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.